SM. Vaccines to prevent pneumococcal community-acquired pneumonia. Clin Chest Med. 2018;39(4):733–52. https://pubmed.ncbi.nlm.nih.gov/30390745/

4734

van Werkhoven CH, Huijts SM. Vaccines to prevent pneumococcal community-acquired pneumonia. Clin Chest Med. 2018;39(4):733–52. https://pubmed.ncbi.nlm.nih.gov/30390745/

4735

US Department of Health and Human Services. Antibiotics resistance threats in the United States: 2019. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf. Centers for Disease Control and Prevention, US Dept of Health and Human Services. Updated December 2019. Accessed May 20, 2022.; https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf

4736

Crooke SN, Ovsyannikova IG, Poland GA, Kennedy RB. Immunosenescence and human vaccine immune responses. Immun Ageing. 2019;16:25. https://pubmed.ncbi.nlm.nih.gov/31528180/

4737

Thomas RE. Pneumococcal pneumonia and invasive pneumococcal disease in those 65 and older: rates of detection, risk factors, vaccine effectiveness, hospitalisation and mortality. Geriatrics (Basel). 2021;6(1):13. https://pubmed.ncbi.nlm.nih.gov/33557406/

4738

Jaiswal V, Ang SP, Lnu K, et al. Effect of pneumococcal vaccine on mortality and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Med. 2022;11(13):3799. https://pubmed.ncbi.nlm.nih.gov/35807082/

4739

Ecarnot F, Bernabei R, Gabutti G, et al. Adult vaccination as the cornerstone of successful ageing: the case of herpes zoster vaccination. A European Interdisciplinary Council on Ageing (EICA) expert focus group. Aging Clin Exp Res. 2019;31(3):301–7. https://pubmed.ncbi.nlm.nih.gov/30805865/

4740

McElhaney JE, Verschoor C, Pawelec G. Zoster vaccination in older adults: efficacy and public health implications. J Gerontol A Biol Sci Med Sci. 2019;74(8):1239–43. https://pubmed.ncbi.nlm.nih.gov/30945744/

4741

Gagliardi AMZ, Andriolo BNG, Torloni MR, et al. Vaccines for preventing herpes zoster in older adults. Cochrane Database Syst Rev. 2019;2019(11):CD008858. https://pubmed.ncbi.nlm.nih.gov/26937872/

4742

Schmader K. Herpes zoster. Ann Intern Med. 2018;169(3):ITC17. https://pubmed.ncbi.nlm.nih.gov/30083718/

4743

Schmader K. Herpes zoster. Ann Intern Med. 2018;169(3):ITC17. https://pubmed.ncbi.nlm.nih.gov/30083718/

4744

Zuin M, Rigatelli G, Adami A. Cerebrovascular events after herpes zoster infection: a risk that should be not underestimated. J Neurovirol. 2019;25(4):439–47. https://pubmed.ncbi.nlm.nih.gov/31069708/

4745

Johnson RW, Levin MJ. Herpes zoster and its prevention by vaccination. Interdiscip Top Gerontol Geriatr. 2020;43:131–45. https://pubmed.ncbi.nlm.nih.gov/32305975/

4746

Coll PP, Costello VW, Kuchel GA, Bartley J, McElhaney JE. The prevention of infections in older adults: vaccination. J Am Geriatr Soc. 2020;68(1):207–14. https://pubmed.ncbi.nlm.nih.gov/31613000/

4747

Shafran SD. Prevention of shingles: better protection and better value with recombinant vaccine. Ann Intern Med. 2019;170(6):416–7. https://pubmed.ncbi.nlm.nih.gov/30776802/

4748

Schmader K. Herpes zoster. Ann Intern Med. 2018;169(3):ITC17. https://pubmed.ncbi.nlm.nih.gov/30083718/

4749

Shafran SD. Prevention of shingles: better protection and better value with recombinant vaccine. Ann Intern Med. 2019;170(6):416–7. https://pubmed.ncbi.nlm.nih.gov/30776802/

4750

Johnson RW, Levin MJ. Herpes zoster and its prevention by vaccination. Interdiscip Top Gerontol Geriatr. 2020;43:131–45. https://pubmed.ncbi.nlm.nih.gov/32305975/

4751

Le P. Which shingles vaccine for older adults? BMJ. 2018;363:k4203. https://pubmed.ncbi.nlm.nih.gov/30361204/

4752

Thijssen E, van Caam A, van der Kraan PM. Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue and dyslipidaemia in obesity-induced osteoarthritis. Rheumatology (Oxford). 2015;54(4):588–600. https://pubmed.ncbi.nlm.nih.gov/25504962/

4753

Kulkarni K, Karssiens T, Kumar V, Pandit H. Obesity and osteoarthritis. Maturitas. 2016;89:22–8. https://pubmed.ncbi.nlm.nih.gov/27180156/

4754

Charlesworth J, Fitzpatrick J, Perera NKP, Orchard J. Osteoarthritis – a systematic review of long-term safety implications for osteoarthritis of the knee. BMC Musculoskelet Disord. 2019;20(1):151. https://pubmed.ncbi.nlm.nih.gov/30961569/

4755

Berenbaum F, Walker C. Osteoarthritis and inflammation: a serious disease with overlapping phenotypic patterns. Postgrad Med. 2020;132(4):377–84. https://pubmed.ncbi.nlm.nih.gov/32100608/

4756

Gress K, Charipova K, An D, et al. Treatment recommendations for chronic knee osteoarthritis. Best Pract Res Clin Anaesthesiol. 2020;34(3):369–82. https://pubmed.ncbi.nlm.nih.gov/33004154/

4757

Leopoldino AO, Machado GC, Ferreira PH, et al. Paracetamol versus placebo for knee and hip osteoarthritis. Cochrane Database Syst Rev. 2019;2019(2):CD013273. https://pubmed.ncbi.nlm.nih.gov/30801133/

4758

Negrini F, Negrini S. Is paracetamol better than placebo for knee and hip osteoarthritis? A Cochrane review summary with commentary. Int J Rheum Dis. 2020;23(4):595–6. https://pubmed.ncbi.nlm.nih.gov/32286015/

4759

Leopoldino AO, Machado GC, Ferreira PH, et al. Paracetamol versus placebo for knee and hip osteoarthritis. Cochrane Database Syst Rev. 2019;2019(2):CD013273. https://pubmed.ncbi.nlm.nih.gov/30801133/

4760

Negrini F, Negrini S. Is paracetamol better than placebo for knee and hip osteoarthritis? A Cochrane review summary with commentary. Int J Rheum Dis. 2020;23(4):595–6. https://pubmed.ncbi.nlm.nih.gov/32286015/

4761

Bunchorntavakul C, Reddy KR. Acetaminophen (APAP or N-acetyl-p-aminophenol) and acute liver failure. Clin Liver Dis. 2018;22(2):325–46. https://pubmed.ncbi.nlm.nih.gov/29605069/

4762

Conaghan PG, Arden N, Avouac B, Migliore A, Rizzoli R. Safety of paracetamol in osteoarthritis: what does the literature say? Drugs Aging. 2019;36(Suppl 1):7–14. https://pubmed.ncbi.nlm.nih.gov/31073920/

4763

Machado GC, Maher CG, Ferreira PH, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ. 2015;350:h1225. https://pubmed.ncbi.nlm.nih.gov/25828856/

4764

Berenbaum F, Walker C. Osteoarthritis and inflammation: a serious disease with overlapping phenotypic patterns. Postgrad Med. 2020;132(4):377–84. https://pubmed.ncbi.nlm.nih.gov/32100608/

4765

Chow YY, Chin KY. The role of inflammation in the pathogenesis of osteoarthritis. Mediators Inflamm. 2020;2020:8293921. https://pubmed.ncbi.nlm.nih.gov/32189997/

4766

Cooper C, Chapurlat R, Al-Daghri N, et al. Safety of oral non-selective non-steroidal anti-inflammatory drugs in osteoarthritis: what does the literature say? Drugs Aging. 2019;36(Suppl 1):15–24. https://pubmed.ncbi.nlm.nih.gov/31073921/

4767

Ho KY, Cardosa MS, Chaiamnuay S, et al. Practice advisory on the appropriate use of NSAIDs in primary care. J Pain Res. 2020;13:1925–39. https://pubmed.ncbi.nlm.nih.gov/32821151/

4768

Cooper C, Chapurlat R, Al-Daghri N, et al. Safety of oral non-selective non-steroidal anti-inflammatory drugs